7 Results for "

pepsin secretion

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "pepsin secretion" in MCE Product Catalog:

14
14 Cited Publications
Cat. No.: HY-10472
CAS No.: 1194044-20-6
Purity:  99.62%
Target:  

Beta-secretase

Research Areas:  

Neurological Disease

LY2811376 is the first orally available non-peptidic β-secretase (BACE1) inhibitor with IC50 of 239 nM-249 nM, that acts to decrease Aβ secretion with EC50 of 300 nM, and demonstrates to have 10-fold selectivity towards BACE1 over BACE2, and more than 50-fold inhibition over other aspartic proteases including cathepsin D, pepsin, or renin.
loading...
    loading...
Cat. No.: HY-129415
CAS No.: 64204-55-3
Synonyms: Hexaprazole
Target:  

Drug Derivative

Research Areas:  

Others

Esaprazole (Hexaprazole) is an antiulcer agent that has the effect of promoting the healing of peptic ulcer. Esaprazole can inhibit the secretion of gastric acid and pepsin .
loading...
    loading...
Cat. No.: HY-106550
CAS No.: 73121-56-9
Synonyms: RS 84135
Research Areas:  

Endocrinology

Enprostil (RS 84135) is a prostaglandin E2 derivative. Enprostil can inhibit amogastrin-stimulated gastric acid secretion, as well as reducing the secretion of pepsin. Enprostil can also serve as an antiulcer agent, used for research of duodenal or gastric ulcers .
loading...
    loading...
Cat. No.: HY-W516943
CAS No.: 700-07-2
CI-624 decrease secretion volumes and outputs of hydrogen, sodium and potassium ions and of pepsin. CI-624 can be used in the research of cancer and autoimmune diseases .
loading...
    loading...
Cat. No.: HY-W747307
CAS No.: 89648-76-0
Research Areas:  

Inflammation/Immunology

FCE 20700 is an orally active PGE2 analogue. FCE 20700 can prevent gastric mucosal damage and in inhibit gastric acid and pepsin secretion. FCE 20700 can be used for the research of gastrointestinal ulcer .
loading...
    loading...
Cat. No.: HY-124203
CAS No.: 64099-44-1
Synonyms: LM 24056
Target:  

Calmodulin mAChR

Research Areas:  

Inflammation/Immunology

Quisultidine (LM 24056) is an orally active phenothiazine derivative with both calmodulin (Calmodulin) inhibitory activity (with a IC50 of 55 μM against porcine calmodulin) and muscarinic acetylcholine receptor (mAChR) ligand activity (with a IC50 of 400 nM). It inhibits gastric acid and pepsin secretion, reduces circulating gastrin levels, and blocks histamine-stimulated gastric acid secretion. Quisultidine can be used in the research of duodenal ulcer .
loading...
    loading...
Cat. No.: HY-10472R
CAS No.: 1194044-20-6
Research Areas:  

Neurological Disease

LY2811376 (Standard) is the analytical standard of LY2811376 (HY-10472). This product is intended for research and analytical applications. LY2811376 is the first orally available non-peptidic β-secretase (BACE1) inhibitor with IC50 of 239 nM-249 nM, that acts to decrease Aβ secretion with EC50 of 300 nM, and demonstrates to have 10-fold selectivity towards BACE1 over BACE2, and more than 50-fold inhibition over other aspartic proteases including cathepsin D, pepsin, or renin.
loading...
    loading...